Tempus AI, Inc. (NASDAQ:TEM) is without doubt one of the finest digital well being shares to purchase now.
Wall Avenue sentiment towards Tempus AI strengthened on November 5, 2025, following the corporate’s Q3 outcomes, with three main companies reiterating constructive rankings and updating their targets. Canaccord Genuity saved its Purchase ranking however trimmed its goal barely from $110 to $95.
In its commentary, Canaccord famous that “AI deployment at scale in medical follow might drive sturdy long-term income development for Tempus AI.”
every part attainable/Shutterstock.com
Tempus’ blowout Q3 wasn’t magic; it was combine and scale. The Ambry-boosted genomics engine did the heavy lifting, with oncology check volumes up ~27% and hereditary testing surging, pushing complete genomics income to ~$253M and total gross sales to $334M. Information/Providers grew too, with Insights licensing main there, so mounted prices unfold wider, lifting gross revenue to ~$210M and tipping adjusted EBITDA constructive. But GAAP stayed purple because of inventory comp, new Ambry amortization, and a $12M debt-extinguishment hit. Administration raised the full-year bar as a result of these development levers look sturdy; the market’s wobble was about prices and future spend, not demand.
Tempus AI, Inc. (NASDAQ:TEM) is a health-tech firm that applies synthetic intelligence to medical and molecular information, aiming to personalize therapy, particularly in oncology, and prolong its know-how throughout a wider vary of illnesses.
Whereas we acknowledge the potential of TEM as an funding, we imagine sure AI shares supply better upside potential and carry much less draw back threat. In the event you’re on the lookout for a particularly undervalued AI inventory that additionally stands to profit considerably from Trump-era tariffs and the onshoring development, see our free report on the finest short-term AI inventory.
READ NEXT: 30 Shares That Ought to Double in 3 Years and 11 Hidden AI Shares to Purchase Proper Now.
Disclosure: None.
![[Pastilan] We’ve seen a presidential forerunner crushed by corruption points earlier than](https://www.rappler.com/tachyon/2026/01/is-Sara-Duterte-a-sure-winner-in-the-2028-presidential-race-ot-so-fast.jpg "[Pastilan] We’ve seen a presidential forerunner crushed by corruption points earlier than")
%20top%20art%20122025%20SOURCE%20Molly%20Higgins.jpg "Right here’s What It’s Prefer to Use Acuity Scheduling for Your Enterprise or Aspect Hustle (2026)")
